3rd Therapeutics Discovery
Convention Center, KSAU-HS. 10-11-12 October 2023
2023-10-10 03:00:00
Registration
Abstract Submission
  • ABSTRACT SUBMISSION
  • Home
  • About
    • OBJECTIVES
    • EXECUTIVE DIRECTOR MESSAGE
    • CONFERENCE CHAIRMAN MESSAGE
    • CONTACT US
  • SPEAKERS
    • SPEAKER LIST
    • MEET THE EXPERTS
  • PROGRAM
    • CONFERENCE PROGRAM
    • PRE-CONFERENCE WORKHOPS
  • EVENT DETAILS
    • REGISTERATION
      • ATTEND THE CONFERENCE
    • ABSTRACT SUBMISSION
      • ABSTRACT SUBMISSION
    • CONFERENCE DETAILS
      • ORGANIZERS
    • POSTERS
      • EVENT POSTER
      • POSTER TEMPLATE
      • POSTER GUIDELINES
      • POSTER REVIEW PANEL
    • CME
      • CME
  • Home
  • About
    • OBJECTIVES
    • EXECUTIVE DIRECTOR MESSAGE
    • CONFERENCE CHAIRMAN MESSAGE
    • CONTACT US
  • SPEAKERS
    • SPEAKER LIST
    • MEET THE EXPERTS
  • PROGRAM
    • CONFERENCE PROGRAM
    • PRE-CONFERENCE WORKHOPS
  • EVENT DETAILS
    • REGISTERATION
      • ATTEND THE CONFERENCE
    • ABSTRACT SUBMISSION
      • ABSTRACT SUBMISSION
    • CONFERENCE DETAILS
      • ORGANIZERS
    • POSTERS
      • EVENT POSTER
      • POSTER TEMPLATE
      • POSTER GUIDELINES
      • POSTER REVIEW PANEL
    • CME
      • CME
164133_Rodon_J-728x728

Dr. Jordi Rodon

Jordi Rodón Ahnert, MD, PhD specializes in early drug development, biomarker discovery, personalized cancer medicine, and neuro-oncology. He is now at MD Anderson’s Investigational Cancer Therapeutics department after moving from Barcelona, where he has been the director and clinical head of the Research Unit for Molecular Therapy of Cancer at the Vall d’Hebron University Hospital in Barcelona, Spain.  Within this unit, he served as clinical head of the Early Clinical Drug Development Group, which aims to develop best-in-class targeted therapies, determine patient populations most likely to benefit using personalized molecular characterization, and identify biomarkers of response. At Vall d’Hebron University Hospital he was also in charge of the Neuroncology program, building it in collaboration with the Phase I Unit, the multidisciplinary clinic and the Gene Expression and Cancer Laboratory leaded by Joan Seoane.

Therapeutics Discovery. 10-11-12 October 2023
Contact us

Contacts
KSAU-HS, Al Hars Al Watani, Ar Rimayah Riyadh 14611 Saudi Arabia
KAIMRC-Therapeutics@ngha.med.sa
LINKS
  • Therapeutics Discovery Conference
  • Objectives
  • About Therapeutics Discovery Conference
© 2021 KAIMRC - Advance Computing & Technologies, All Rights Reserved.